SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-002979
Filing Date
2021-02-26
Accepted
2021-02-26 17:15:40
Documents
3
Period of Report
2021-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_022321.htm 8-K 32598
2 EMPLOYMENT AGREEMENT, DATED FEBRUARY 23, 2021, BETWEEN THE COMPANY AND JESSICA M ex10-01.htm EX-10.01 108465
3 EMPLOYMENT AGREEMENT, DATED FEBRUARY 23, 2021, BETWEEN THE COMPANY AND BRADLEY S ex10-02.htm EX-10.02 108682
  Complete submission text file 0001387131-21-002979.txt   251037
Mailing Address 28 MAIN STREET CHATHAM NJ 07928
Business Address 28 MAIN STREET CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 21691095
SIC: 2834 Pharmaceutical Preparations